Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD43 antibody (FITC)

The Mouse Monoclonal anti-CD43 antibody is suitable to detect CD43 in samples from Human. It has been validated for FACS, WB and IHC.
Catalog No. ABIN2226425
$742.57
Plus shipping costs $50.00
120 tests
Shipping to: United States
Delivery in 21 to 26 Business Days

Quick Overview for CD43 antibody (FITC) (ABIN2226425)

Target

See all CD43 (SPN) Antibodies
CD43 (SPN) (Sialophorin (SPN))

Reactivity

  • 150
  • 17
  • 16
  • 1
  • 1
Human

Host

  • 86
  • 84
  • 7
  • 1
Mouse

Clonality

  • 108
  • 66
  • 4
Monoclonal

Conjugate

  • 82
  • 16
  • 15
  • 15
  • 9
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD43 antibody is conjugated to FITC

Application

  • 114
  • 100
  • 78
  • 53
  • 44
  • 30
  • 24
  • 13
  • 6
  • 6
  • 6
  • 4
  • 4
  • 4
  • 3
  • 1
  • 1
Flow Cytometry (FACS), Western Blotting (WB), Immunohistochemistry (IHC)

Clone

7H182
  • Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu

    Characteristics

    CD43 (T Cell Marker, Leukosialin, Sialophorin, or Leukocyte Sialoglycoprotein) (FITC)

    Purification

    Purified by Protein A affinity chromatography.

    Immunogen

    Human KG-1 tumor cells

    Isotype

    IgG1
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, pH 7.2, 5 % glycerol, 0.2 % BSA, 0.05 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    CD43 (SPN) (Sialophorin (SPN))

    Alternative Name

    CD43

    Pathways

    Regulation of Leukocyte Mediated Immunity
You are here:
Chat with us!